Adverse events (AEs) in phase III clinical trials of patients with human epidermal growth factor receptor-2 positive (HER2+) breast cancer (BC): a meta-analysis

Authors
Category Systematic review
JournalCANCER RESEARCH
Year 2023
This article has no abstract
Epistemonikos ID: 0e1622a0da271fa3acb1302287f61da95da403cc
First added on: Feb 15, 2025